“Patient journeys” is an initiative designed to help patients and clinicians improve care for rare lung diseases, including pulmonary…
Teresa Carvalho, MS
Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Teresa Carvalho, MS
A total of approximately 5.8 new cases per one million inhabitants was found to be the most accurate value for…
United Therapeutics is now among the leading sponsors of the Pulmonary Fibrosis Foundation (PFF) Registry, a research data resource…
A bike competition to educational meetings and daily walks, runs, or meditations are among the events Team PHenomenal Hope is…
The Pulmonary Hypertension Association (PHA) is promoting several events throughout November — the Pulmonary Hypertension (PH) Awareness Month.
Letairis (ambrisentan), an approved therapy for pulmonary arterial hypertension (PAH) in adults, appears to also be effective and safe in…
Pulmonary hypertension (PH) may be induced by an increased dosage of diazoxide, a therapy used to treat low…